1h Free Analyst Time
The RhD Blood Grouping Reagent Kit stands at the forefront of immunohematology, ensuring precise detection of RhD antigens for safe blood transfusions, prenatal care, and disease management. With RhD mismatches posing serious risks-including hemolytic disease of the fetus and newborn and potentially life-threatening transfusion reactions-the demand for reliable reagents is critical. Recent advancements in reagent quality, coupled with stringent regulatory guidelines, have elevated expectations for sensitivity and specificity. Furthermore, the convergence of technological innovation and evolving clinical practices has driven laboratories and healthcare facilities to prioritize high-performance RhD kits. As the global healthcare community intensifies efforts to minimize transfusion-related complications and optimize prenatal screening protocols, the RhD Blood Grouping Reagent Kit has become an indispensable tool. This introduction sets the stage for a detailed analysis of emerging shifts, regulatory impacts, segmentation insights, regional dynamics, competitive positioning, and strategic recommendations, offering a comprehensive view of the factors shaping the future of RhD reagent solutions.Speak directly to the analyst to clarify any post sales queries you may have.
Transformative Shifts Reshaping RhD Reagent Solutions
The landscape of RhD Blood Grouping Reagent Kits is undergoing transformative shifts driven by technological breakthroughs, regulatory modernization, and evolving clinical demands. Automated systems are streamlining workflows, reducing manual errors, and accelerating turnaround times, while traditional slide and tube methods remain essential in resource-constrained settings. Concurrently, molecular typing techniques-leveraging DNA sequencing and advanced PCR platforms-are expanding the toolkit for precise Rh genotyping, facilitating early detection of RhD incompatibilities in prenatal testing and complex transfusion scenarios. Additionally, the integration of digital data management and connectivity solutions is enhancing traceability and compliance, aligning with global efforts to strengthen patient safety. Emerging markets are witnessing increased adoption of monoclonal reagent kits owing to consistent performance, whereas polyclonal kits maintain relevance where broad antigen recognition is required. In parallel, research institutes are exploring novel reagent formulations to address rare Rh variants. These collective developments signal a shift toward greater automation, deeper molecular insights, and enhanced quality control, fundamentally redefining the standards for RhD blood grouping.Cumulative Impact of 2025 United States Tariffs
The implementation of the United States tariffs in 2025 has introduced a new dimension of operational complexity for suppliers and end users of RhD Blood Grouping Reagent Kits. Increased import duties on specialty reagents and instrumentation components have elevated input costs, prompting manufacturers to reassess supply chain strategies. Many exporters are negotiating pricing adjustments or absorbing partial tariff impacts to remain competitive, while strategic alliances with domestic producers are emerging to mitigate cross-border cost burdens. Moreover, these tariffs have accelerated localization initiatives, with key players establishing regional manufacturing hubs to bypass trade barriers and secure uninterrupted reagent availability. End users-including diagnostic laboratories and hospitals-are responding by optimizing inventory management protocols, consolidating purchases through direct sales agreements, or exploring alternative distribution channels to control expenses. Regulatory bodies are closely monitoring price fluctuations to safeguard equitable access to critical blood grouping reagents. Collectively, the 2025 tariff measures are reshaping sourcing strategies, driving innovation in reagent production, and catalyzing collaborations aimed at maintaining affordability and reliability in RhD testing.Key Segmentation Insights Across Multiple Dimensions
Insight into market segmentation underscores the multifaceted dynamics at play. By product type, the market encompasses combinational blood grouping kits, which integrate ABO grouping and Rh(D) typing for streamlined testing workflows, standalone RhD reagent kits that cater to focused immunohematology applications, as well as monoclonal and polyclonal reagent kits that offer distinct specificity and sensitivity profiles. On the end-user front, academic and research institutes leverage these kits for investigative studies, blood banks require robust reagents for large-scale donor screening, diagnostic laboratories prioritize high-throughput solutions for routine blood testing, and hospitals and clinics depend on rapid results to guide transfusion medicine. Application-based segmentation reveals demand across disease management protocols, routine blood testing, and transfusion medicine, with prenatal testing subdivided into fetal RHD screening for early risk assessment and broader pregnancy screening to detect potential Rh incompatibilities. Technological segmentation highlights the rise of automated systems, the growing prevalence of molecular typing methods such as DNA sequencing and PCR techniques, alongside the continued relevance of traditional blood grouping approaches. Age group analysis spans adult, elderly, and pediatric patient populations, each presenting unique reagent performance requirements. Price range segmentation differentiates between budget friendly, mid-range, and premium offerings, while distribution channels vary from direct sales and distributor networks to online platforms that enhance accessibility. This comprehensive segmentation framework offers a clear guide for stakeholders to align product development, marketing strategies, and supply chain decisions with evolving market demands.Key Regional Insights Influencing Market Growth
Regional dynamics in the RhD Blood Grouping Reagent Kit market reveal distinct opportunities and challenges. In the Americas, robust healthcare infrastructure and progressive reimbursement policies support widespread adoption of advanced reagent solutions, while ongoing investment in blood safety initiatives fuels demand. Shifting regulatory requirements and consolidated procurement practices are encouraging local manufacturing partnerships. In Europe, Middle East & Africa, diverse economic conditions and healthcare delivery models-ranging from high-income Western European nations to emerging African markets-necessitate adaptable reagent portfolios. Here, compliance with stringent European CE-mark standards coexists with tailored offerings for resource-limited settings, particularly in Sub-Saharan Africa where transfusion safety is a critical public health priority. The Asia-Pacific region is characterized by rapid modernization of healthcare systems, increasing birth rates fueling prenatal screening volumes, and expanding diagnostic laboratory networks in countries such as China and India. Government initiatives to strengthen transfusion services and growing awareness of hemolytic disease prevention are driving demand for both cost-effective traditional reagents and sophisticated molecular typing kits. Collectively, these regional insights underscore the need for flexible manufacturing, regulatory agility, and tailored go-to-market strategies.Key Company Profiles and Competitive Landscape
The competitive landscape is shaped by established industry leaders and innovative specialists. Abbott Laboratories has leveraged its global footprint and comprehensive portfolio to deliver integrated immunohematology solutions. BD (Becton, Dickinson and Company) combines technological expertise in automated systems with a strong distribution network, while Beckman Coulter, Inc. focuses on high-throughput platforms that support large-scale blood screening programs. Bio-Rad Laboratories, Inc. and Bio-Techne Corporation emphasize reagent quality and research-grade offerings suitable for specialized laboratories, and Diagast has prioritized precision reagents for rare blood group variants. Grifols, S.A. integrates plasma-derived reagents within its transfusion medicine ecosystem, whereas Immucor, Inc. advances molecular typing through targeted PCR assays. Kantaro Biosciences delivers niche solutions for fetal RHD screening, complementing the broader diagnostic portfolios of Merck KGaA and MilliporeSigma. Ortho Clinical Diagnostics Holdings plc and QuidelOrtho Corporation sustain leadership in automated immunohematology instrumentation, Siemens Healthineers AG drives innovation in system connectivity and digital workflows, and Thermo Fisher Scientific Inc. leverages its extensive reagent manufacturing capabilities to support diverse end users. This diverse mix of global and regional players fosters competitive intensity and stimulates continuous product innovation.Actionable Recommendations for Industry Leaders
Industry leaders should adopt a multi-pronged strategy to capitalize on emerging trends and fortify market position. First, investing in modular automation platforms that support both traditional slide-based protocols and advanced molecular typing will cater to diverse end-user needs and future-proof reagent portfolios. Second, forging strategic alliances with regional manufacturers can mitigate tariff impacts and improve supply chain resilience, ensuring continuity of reagent availability amid trade fluctuations. Third, expanding reagent lines to address rare RhD variants and niche prenatal applications will differentiate offerings and capture underserved segments. Fourth, enhancing digital integration-through cloud-based traceability, data analytics, and artificial intelligence-driven quality control-will bolster compliance and create value for high-volume laboratories. Fifth, implementing tiered pricing models aligned with budget friendly, mid-range, and premium segments will optimize market penetration across clinics, diagnostic centers, and research institutions. Finally, strengthening direct sales channels and digital ordering platforms will streamline procurement processes and enhance customer engagement. By executing these targeted measures, companies can accelerate growth, improve operational efficiency, and deliver superior value to end users.Conclusion and Strategic Outlook
As the RhD Blood Grouping Reagent Kit market evolves through technological innovation, regulatory shifts, and complex trade dynamics, stakeholders must remain agile and customer-centric. Embracing automation and molecular typing advances will address rising demands for precision and throughput. Meanwhile, strategic sourcing and localized production will attenuate the effects of tariffs, safeguarding affordability and supply consistency. A nuanced understanding of product, end-user, application, technology, age group, price range, and distribution channel segmentation will empower companies to tailor solutions that resonate with diverse market segments. Regional insights highlight the importance of regulatory alignment, manufacturing flexibility, and localized engagement. Competitive benchmarking underscores the value of collaboration, digital integration, and continuous product refinement. Through disciplined execution of recommended strategies and steadfast commitment to quality, industry participants can navigate the complexities of the current environment and deliver impactful solutions that enhance transfusion safety, prenatal care, and overall patient outcomes.Market Segmentation & Coverage
This research report categorizes the RhD Blood Grouping Reagent Kit Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Combinational Blood Grouping Kits
- ABO Grouping
- Rh(D) Typing
- Monoclonal Reagent Kits
- Polyclonal Reagent Kits
- Standalone RhD Blood Grouping Kits
- Academic and Research Institutes
- Blood Banks
- Diagnostic Laboratories
- Hospitals and Clinics
- Disease Management
- Prenatal Testing
- Fetal RHD Screening
- Pregnancy Screening
- Routine Blood Testing
- Transfusion Medicine
- Automated Systems
- Molecular Typing
- DNA Sequencing
- PCR Techniques
- Traditional Blood Grouping
- Adults
- Elderly
- Pediatrics
- Budget Friendly
- Mid-Range
- Premium
- Direct Sales
- Distributors
- Online Platforms
This research report categorizes the RhD Blood Grouping Reagent Kit Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the RhD Blood Grouping Reagent Kit Market to delves into recent significant developments and analyze trends in each of the following companies:
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Diagast
- Grifols, S.A.
- Immucor, Inc.
- Kantaro Biosciences
- Merck KGaA
- MilliporeSigma (part of Merck KGaA)
- Ortho Clinical Diagnostics Holdings plc
- QuidelOrtho Corporation
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. RhD Blood Grouping Reagent Kit Market, by Product Type
8.1. Introduction
8.2. Combinational Blood Grouping Kits
8.2.1. ABO Grouping
8.2.2. Rh(D) Typing
8.3. Monoclonal Reagent Kits
8.4. Polyclonal Reagent Kits
8.5. Standalone RhD Blood Grouping Kits
9. RhD Blood Grouping Reagent Kit Market, by End User
9.1. Introduction
9.2. Academic and Research Institutes
9.3. Blood Banks
9.4. Diagnostic Laboratories
9.5. Hospitals and Clinics
10. RhD Blood Grouping Reagent Kit Market, by Application
10.1. Introduction
10.2. Disease Management
10.3. Prenatal Testing
10.3.1. Fetal RHD Screening
10.3.2. Pregnancy Screening
10.4. Routine Blood Testing
10.5. Transfusion Medicine
11. RhD Blood Grouping Reagent Kit Market, by Technology
11.1. Introduction
11.2. Automated Systems
11.3. Molecular Typing
11.3.1. DNA Sequencing
11.3.2. PCR Techniques
11.4. Traditional Blood Grouping
12. RhD Blood Grouping Reagent Kit Market, by Age Group
12.1. Introduction
12.2. Adults
12.3. Elderly
12.4. Pediatrics
13. RhD Blood Grouping Reagent Kit Market, by Price Range
13.1. Introduction
13.2. Budget Friendly
13.3. Mid-Range
13.4. Premium
14. RhD Blood Grouping Reagent Kit Market, by Distribution Channel
14.1. Introduction
14.2. Direct Sales
14.3. Distributors
14.4. Online Platforms
15. Americas RhD Blood Grouping Reagent Kit Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific RhD Blood Grouping Reagent Kit Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa RhD Blood Grouping Reagent Kit Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. BD (Becton, Dickinson and Company)
18.3.3. Beckman Coulter, Inc.
18.3.4. Bio-Rad Laboratories, Inc.
18.3.5. Bio-Techne Corporation
18.3.6. Diagast
18.3.7. Grifols, S.A.
18.3.8. Immucor, Inc.
18.3.9. Kantaro Biosciences
18.3.10. Merck KGaA
18.3.11. MilliporeSigma (part of Merck KGaA)
18.3.12. Ortho Clinical Diagnostics Holdings plc
18.3.13. QuidelOrtho Corporation
18.3.14. Siemens Healthineers AG
18.3.15. Thermo Fisher Scientific Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. RHD BLOOD GROUPING REAGENT KIT MARKET MULTI-CURRENCY
FIGURE 2. RHD BLOOD GROUPING REAGENT KIT MARKET MULTI-LANGUAGE
FIGURE 3. RHD BLOOD GROUPING REAGENT KIT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. RHD BLOOD GROUPING REAGENT KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. RHD BLOOD GROUPING REAGENT KIT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RHD BLOOD GROUPING REAGENT KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ABO GROUPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY RH(D) TYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MONOCLONAL REAGENT KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY POLYCLONAL REAGENT KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY STANDALONE RHD BLOOD GROUPING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISEASE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY FETAL RHD SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PREGNANCY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ROUTINE BLOOD TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TRANSFUSION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PCR TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TRADITIONAL BLOOD GROUPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY BUDGET FRIENDLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MID-RANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PREMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 79. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 82. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 84. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 86. CANADA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 92. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 94. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 95. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 131. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 134. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 136. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 138. CHINA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 141. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 144. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 146. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 148. INDIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 161. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 164. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 166. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 168. JAPAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 186. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 188. PHILIPPINES RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 196. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 198. SINGAPORE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 206. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH KOREA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 216. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 218. TAIWAN RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 221. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 224. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 226. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 228. THAILAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 236. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 238. VIETNAM RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 250. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 252. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 255. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 257. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 258. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 259. DENMARK RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 262. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 265. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 267. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 269. EGYPT RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 272. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 275. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 277. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 278. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 279. FINLAND RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 282. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 285. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 287. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 289. FRANCE RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 292. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 295. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY MOLECULAR TYPING, 2018-2030 (USD MILLION)
TABLE 297. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 298. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRICE RANGE, 2018-2030 (USD MILLION)
TABLE 299. GERMANY RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY COMBINATIONAL BLOOD GROUPING KITS, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL RHD BLOOD GROUPING REAGENT KIT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL RHD BLOOD GROUPING REAGENT
Companies Mentioned
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Diagast
- Grifols, S.A.
- Immucor, Inc.
- Kantaro Biosciences
- Merck KGaA
- MilliporeSigma (part of Merck KGaA)
- Ortho Clinical Diagnostics Holdings plc
- QuidelOrtho Corporation
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
